These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24580033)

  • 21. What are parents' perspectives on psychological empowerment in the MMR vaccination decision? A focus group study.
    Fadda M; Galimberti E; Carraro V; Schulz PJ
    BMJ Open; 2016 Apr; 6(4):e010773. PubMed ID: 27084284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Just that little bit of doubt': Scottish parents', teenage girls' and health professionals' views of the MMR, H1N1 and HPV vaccines.
    Kennedy C; Gray Brunton C; Hogg R
    Int J Behav Med; 2014 Feb; 21(1):3-10. PubMed ID: 24198038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.
    Yadav S; Thukral R; Chakarvarti A
    Indian J Med Res; 2003 Nov; 118():183-6. PubMed ID: 14723482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mothers' management of childhood diseases in Yorubaland: the influence of cultural beliefs.
    Feyisetan BJ; Asa S; Ebigbola JA
    Health Transit Rev; 1997 Oct; 7(2):221-34. PubMed ID: 10176379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMR vaccination: answers to some parents' questions.
    Moreton J
    J Fam Health Care; 2002; 12(6):151-3. PubMed ID: 12630143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing MMR vaccination decisions following a mumps outbreak on a university campus.
    Hamilton-West K
    Vaccine; 2006 Jun; 24(24):5183-91. PubMed ID: 16650916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
    Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.
    Mrozek-Budzyn D; Kiełtyka A; Majewska R
    Pediatr Infect Dis J; 2010 May; 29(5):397-400. PubMed ID: 19952979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parents' reported reasons for avoiding MMR vaccination. A telephone survey.
    Dannetun E; Tegnell A; Hermansson G; Giesecke J
    Scand J Prim Health Care; 2005 Sep; 23(3):149-53. PubMed ID: 16162466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Immunisation Beliefs and Intentions Measure (IBIM): predicting parents' intentions to immunise preschool children.
    Tickner S; Leman PJ; Woodcock A
    Vaccine; 2010 Apr; 28(19):3350-62. PubMed ID: 20206284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA
    East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Children's health and the social theory of risk: insights from the British measles, mumps and rubella (MMR) controversy.
    Casiday RE
    Soc Sci Med; 2007 Sep; 65(5):1059-70. PubMed ID: 17540488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review.
    Brown KF; Kroll JS; Hudson MJ; Ramsay M; Green J; Long SJ; Vincent CA; Fraser G; Sevdalis N
    Vaccine; 2010 Jun; 28(26):4235-48. PubMed ID: 20438879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policy.
    Paranthaman K; Bunce A
    Epidemiol Infect; 2012 Sep; 140(9):1612-6. PubMed ID: 22117122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children.
    Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
    Clin Immunol; 2005 May; 115(2):154-61. PubMed ID: 15885638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.